Seres Therapeutics Inc. (MCRB)
0.81
-0.03 (-3.75%)
At close: Jan 28, 2025, 3:59 PM
0.81
-0.58%
After-hours Jan 28, 2025, 05:34 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -1.58 | -2.38 | -12.42 | -22.61 | -3.04 | -1.86 | -4.59 | -4.31 | -15.07 | -91.61 | -250.85 | -340.09 |
| PS Ratio | 1.42 | 84.91 | 5.27 | 58.85 | 5.66 | 6.52 | 12.78 | 18.12 | n/a | n/a | n/a | n/a |
| PB Ratio | -4 | 56.13 | 5.81 | 11.19 | -4.04 | -3.83 | 6.76 | 2.97 | 4.02 | -57.28 | -137.7 | 167.16 |
| P/FCF Ratio | -1.43 | -2.54 | -265.42 | -20.75 | -2.52 | -2.84 | -5.11 | 17.59 | -18.27 | -134.75 | -278.56 | -330.47 |
| P/OCF Ratio | -1.53 | -2.65 | 114.22 | -20.88 | -2.55 | -2.93 | -5.43 | 8.98 | -20.22 | -147.78 | -287.67 | -363.46 |
| OCF/S Ratio | -0.93 | -32.1 | 0.05 | -2.82 | -2.22 | -2.22 | -2.35 | 2.02 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -4.77 | 15.08 | 0.37 | 0.23 | -0.93 | -0.15 | 0.15 | 0.08 | n/a | -0.09 | -0.08 | n/a |
| Quick Ratio | 1.48 | 2.28 | 3.69 | 5.79 | 2.82 | 2.20 | 4.90 | 6.51 | 19.01 | 22.39 | 1.61 | 35.08 |
| Current Ratio | 1.78 | 2.28 | 3.69 | 5.79 | 2.18 | 2.20 | 4.90 | 6.51 | 19.01 | 22.39 | 1.61 | 35.08 |
| Asset Turnover | 0.35 | 0.02 | 0.41 | 0.10 | 0.26 | 0.23 | 0.17 | 0.08 | n/a | n/a | n/a | n/a |
| Interest Coverage | -8.2 | -40.95 | -22.16 | -30.14 | -143.18 | -85.57 | -57.48 | -95.81 | -98.84 | n/a | -144.1 | n/a |
| Return on Equity (ROE) | 2.54 | -23.54 | -0.47 | -0.49 | 1.33 | 2.06 | -1.47 | -0.69 | -0.27 | 0.63 | 0.55 | -0.49 |
| Return on Assets (ROA) | -0.32 | -0.73 | -0.17 | -0.25 | -0.49 | -0.82 | -0.47 | -0.34 | -0.25 | -0.14 | -2.87 | -0.48 |
| Return on Capital (ROIC) | -0.42 | -0.94 | -0.24 | -0.3 | -0.83 | -1.28 | -0.58 | -0.38 | -0.27 | -0.13 | -5.66 | -0.48 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 99.44% | 85.91% | 98.80% | -172.68% | -132.26% | -239.46% | -178.68% | -276.68% | n/a | n/a | n/a | n/a |
| Net Profit Margin | -90.02% | -3.56K% | -42.43% | -260.29% | -186.19% | -350.03% | -278.44% | -420.74% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -90.02% | -3.51K% | -45.25% | -268.33% | -203.68% | -350.03% | -278.44% | -420.74% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -85.48% | -3.46K% | -44.5% | -265.33% | -208.31% | -354.77% | -284.72% | -426.53% | n/a | n/a | n/a | n/a |
| FCF Margin | -99.21% | -3.35K% | -1.99% | -283.61% | -224.67% | -229.21% | -249.84% | 103.05% | n/a | n/a | n/a | n/a |
| EBITDA Margin | -74.65% | -3.33K% | -39.14% | -232.76% | -173.73% | -322.21% | -255.83% | -407.21% | n/a | n/a | n/a | n/a |